Loading...

Rhythm Biosciences Limited

RHY.AX•ASX
Healthcare
Medical - Diagnostics & Research
A$0.06
A$0.00(0.00%)

Rhythm Biosciences Limited (RHY.AX) Company Profile & Overview

Explore Rhythm Biosciences Limited’s business operations, leadership, sector classification, and key company facts including IPO date, industry, and contact details.

Rhythm Biosciences Limited (RHY.AX) Company Profile & Overview

Rhythm Biosciences Limited, a transformative predictive cancer diagnostics technology company in Australia and internationally. The company engages in developing and commercializing medical diagnostics technology. It develops ColoSTAT, a blood test for the early detection of colorectal cancer. The company was incorporated in 2017 and is headquartered in Parkville, Australia.

SectorHealthcare
IndustryMedical - Diagnostics & Research
CEODavid Atkins

Contact Information

https://www.rhythmbio.com
61 3 8256 2880
Bio21 Institute, Parkville, VIC, 3010

Company Facts

IPO DateDec 6, 2017
CountryAU
Actively Trading

Frequently Asked Questions

;